Figure 3
From: Elevated SLC3A2 associated with poor prognosis and enhanced malignancy in gliomas
Pathway enrichment analysis of the DEGs based on the SLC3A2 in gliomas. (A) Volcano plot showing the distribution of DEGs, with red dots representing significantly upregulated DEGs and blue dots representing significantly downregulated DEGs. (B) Co-expression heatmap between SLC3A2 expression and the top 10 DEGs. (C–D) Bubble plots showing the results of GO and KEGG pathway analysis of DEGs.
